Welch Forbes buys $58,787,188 stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Welch Forbes scooped up 9,184 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 2, 2016. The investment management firm now holds a total of 725,947 shares of Danaher Corporation which is valued at $58,787,188.Danaher Corporation makes up approximately 1.74% of Welch Forbes’s portfolio.

Other Hedge Funds, Including , Sumitomo Mitsui Asset Management Company Ltd boosted its stake in DHR in the latest quarter, The investment management firm added 790 additional shares and now holds a total of 47,227 shares of Danaher Corporation which is valued at $3,846,167. Danaher Corporation makes up approx 0.11% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.Farmers Trust Co boosted its stake in DHR in the latest quarter, The investment management firm added 615 additional shares and now holds a total of 7,830 shares of Danaher Corporation which is valued at $636,109. Danaher Corporation makes up approx 0.20% of Farmers Trust Co’s portfolio.Atria Investments reduced its stake in DHR by selling 1,468 shares or 4.55% in the most recent quarter. The Hedge Fund company now holds 30,797 shares of DHR which is valued at $2,495,789. Danaher Corporation makes up approx 0.26% of Atria Investments’s portfolio.Boltwood Capital Management reduced its stake in DHR by selling 380 shares or 1.69% in the most recent quarter. The Hedge Fund company now holds 22,099 shares of DHR which is valued at $1,776,760. Danaher Corporation makes up approx 1.48% of Boltwood Capital Management’s portfolio.

Danaher Corporation closed down -0.22 points or -0.27% at $81.28 with 16,34,579 shares getting traded on Monday. Post opening the session at $81.66, the shares hit an intraday low of $81.2 and an intraday high of $81.7 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.